Evidence map›Paper›PMID 34601140›Full record

ArticleJournal of biomedical informatics2021

A novel deep interval type-2 fuzzy LSTM (DIT2FLSTM) model applied to COVID-19 pandemic time-series prediction.

Aref Safari, Rahil Hosseini, Mahdi Mazinani

Abstract read
In one paragraph

Article in Journal of biomedical informatics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Aref SafariDepartment of Computer Engineering, Shahr-e-Qods Branch, Islamic Azad University, Tehran, Iran.
Rahil HosseiniDepartment of Computer Engineering, Shahr-e-Qods Branch, Islamic Azad University, Tehran, Iran. Electronic address: rahil.hosseini@qodsiau.ac.ir.
Mahdi MazinaniDepartment of Electronic Engineering, Shahr-e-Qods Branch, Islamic Azad University, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Currently, the novel COVID-19 coronavirus has been widely spread as a global pandemic. The COVID-19 pandemic has a major influence on human life, healthcare systems, and the economy. There are a large number of methods available for predicting the incidence of the virus. A complex and non-stationary problem such as the COVID-19 pandemic is characterized by high levels of uncertainty in its behavior during the pandemic time. The fuzzy logic, especially Type-2 Fuzzy Logic, is a robust and capable model to cope with high-order uncertainties associated with non-stationary time-dependent features. The main objective of the current study is to present a novel Deep Interval Type-2 Fuzzy LSTM (DIT2FLSTM) model for prediction of the COVID-19 incidence, including new cases, recovery cases, and mortality rate in both short and long time series. The proposed model was evaluated on real datasets produced by the world health organization (WHO) on top highly risked countries, including the USA, Brazil, Russia, India, Peru, Spain, Italy, Iran, Germany, and the U.K. The results confirm the superiority of the DIT2FLSTM model with an average area under the ROC curve (AUC) of 96% and a 95% confidence interval of [92-97] % in the short-term and long-term. The DIT2FLSTM was applied to a well-known standard benchmark, the Mackey-Glass time-series, to show the robustness and proficiency of the proposed model in uncertain and chaotic time series problems. The results were evaluated using a 10-fold cross-validation technique and statistically validated through the t-test method. The proposed DIT2FLSTM model is promising for the prediction of complex problems such as the COVID-19 pandemic and making strategic prevention decisions to save more lives.

Indexed as

COVID-19PandemicsBrazilFuzzy LogicHumansSARS-CoV-2COVID-19LSTM networkTime series predictionType-2 fuzzy logic

Identifiers

PMID34601140
PMCPMC8482548

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.